Synbio International Inc (ID)【SYIN】株式ニュース

$SYIN - The company put out a PR on January 23rd.

$SYIN -Synbio is overseeing the trial under its clinical and regulatory leadership pursuant to its agreement with FacialDx, the developer of the underlying AI technology. The trial is expected to commence in early 2026 and conclude later in the year.

The last 5 words of that PR tells when the trial will conclude. "LATER IN THE YEAR"

"The study will assess accuracy, reliability, and clinical utility in real-world conditions—data that may support future regulatory submissions and accelerate commercialization efforts. Conducting the trial in Australia offers cost and timeline efficiencies while maintaining globally recognized clinical and ethical standards."

"The company entered into a Master Services Agreement with CRO Services Pty Ltd, a leading Australian clinical research organization and a wholly owned subsidiary of Resonance Health Ltd (ASX: RHT). Under the agreement, CRO Services will conduct a clinical study to evaluate the real-world performance of FacialDx Incorporated’s NIMS™ (Non-invasive Medical Screening) platform, a proprietary AI-based facial analysis technology."

I looked up CRO Services trials and they are shorter than the normal "clinical trials" we would have in the US. My understanding, which seems to be corroborated by the January 23rd PR is that these can take anywhere from 4 months to 6 months.

The good news...these trials are shorter than those in the US, but Australia has reciprocity agreements with both the US and Europe. That means the triial in any of those jurisdictions ias accepted as valid by the other two. So if their trial in Australia is successful, they would have access to both the US and European markets. (Maybe that's why "International" is in their name?

My guess on timing would be that we're looking at the 3rd qtr or even the 4th qtr. I say that because this company hasn't shown that they are in a hurry! I think that's a fair assessment but I could be wrong. GL